Skip to main content
Publications
Auclair D, Mansfield C , Chari A, Cole CE, Fiala MA, Kaufman JL, Orloff G, Siegel DS, Zonder JA, Mange B, Yesil J, Dalal M, Mikhael JR. Patient treatment preferences for relapsed/refractory multiple myeloma: are patients willing to trade off efficacy for tolerability? Presented at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition; December 3, 2018. San Diego, CA. [abstract] Blood. 2018 Nov 29; 132(Supplement 1):614. doi: 10.1182/blood-2018-99-113087
Poulos C , Feldman SR, Gilloteau I, Boeri M, Guana A, Germino B, Boehm K, Gutknecht M, Augustin M. The most influential drivers of psoriasis patients' treatment choice: a discrete choice experiment survey in the US . Poster presented at the 2018 ISPOR 21st Annual European Congress; November 12, 2018. Barcelona, Spain.
Mansfield C , Ekwueme DU, Tangka FKL, Brown DS, Smith JL, Guy, Jr GP, Li C, Hauber B. Colorectal cancer screening: preferences, past behavior, and future intentions . Patient. 2018 Nov 5;11(6):599-611. doi: 10.1007/s40271-018-0308-6
Browne E, Montgomery E, van der Straten A, Boeri M, Mange B, Beksinska M, Schwartz J, Clark M, Doncel G, Smit J, Chirenje ZM, Mansfield C . What do women prefer in a vaginal HIV prevention product? Findings from a discrete choice experiment in Southern Africa . Presented at the HIV Research for Prevention 2018: AIDS Vaccine, Microbicide and ARV-based Prevention Science; October 24, 2018. Madrid, Spain.
Minnis AM, Atujuna M, Browne E, Ndwayana S, Hartmann M, Sindelo S, Ngcwayi N, Boeri M, Mansfield C , Bekker LG, Montgomery ET. Attribute preferences for long-acting Pre-Exposure Prophylaxis (PrEP): results of a discrete choice experiment with South African youth . Presented at the HIV Research for Prevention 2018: AIDS Vaccine, Microbicide and ARV-based Prevention Science; October 23, 2018. Madrid, Spain.
Peay H, Fischer R, Beaverson K, Morris C, Hesterlee SE, Ricotti V, Martin A, Rensch C, Wand H, Mansfield CA . Parent and adult patient attitudes about gene therapy as a therapeutic option for Duchenne Muscular Dystrophy . Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 23, 2018. Baltimore, MD. [abstract] Value Health. 2018 May; 21(Suppl 1):S256.
Lewis MA, Stine A, Paquin RS, Mansfield C , Wood D, Rini C, Roche MI, Powell CM, Berg JS, Bailey, Jr DB. Parental preferences toward genomic sequencing for non-medically actionable conditions in children: a discrete-choice experiment . Genet Med. 2018 Feb;20(2):181-9. doi: 10.1038/gim.2017.93
Postmus D, Richard S, Bere N, van Valkenhoef G, Galinsky J , Low E, Moulon I, Mavris M, Salmonsson T, Flores B, Hillege H, Pignatti F. Individual trade‐offs between possible benefits and risks of cancer treatments: results from a stated preference study with patients with multiple myeloma . Oncologist. 2018 Jan;23(1):44-51. doi: 10.1634/theoncologist.2017-0257